Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Female Reproductive System Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Carcinoma
Genitourinary System Carcinoma
Female Reproductive System Carcinoma

Subtype

Female Reproductive System Carcinoma

CI-CAN-00002685Explore in graph →

458 active trials5 approved drugs36 evidence items

NCIt: C181162

Overview
Statistics
Survival
Genomics34
Variants & evidence36
Drugs19
Trials1481
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

1,481 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 458
Recruiting: 230
Ph III recruiting: 25
Growth YoY: +35.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

StatusAll Active (any)Completed 560 Recruiting 279 Active Not Recruiting 180 Unknown 158 Terminated 157 Not Yet Recruiting 80 Withdrawn 55 Suspended 7 Enrolling By Invitation 4 No Longer Available 1

PhaseAll Early Phase 1 34 N/A 202 Phase 1 430 Phase 2 607 Phase 3 135 Phase 4 11

No study matches these filters